Healthy Extracts Inc (HYEX)

[BluSkies]

GRCK is pending an Eqova update followed by the CBD.co launch.

This is what GRCK shareholders are looking for as far as an update.

UPDATED Upcoming Catalysts:

– Insider Purchases
– Settling or restructuring of Convertible Debt
– Expanding Operations
– Doctor Referrals On Products
– Non CD Financing Deal
X News on canceling RS
– Full time sales REPS
– Sales projections
– 2017 Sales/Revenues
– Regional distributors
X Roll Out New Products
- CBD.co (17 days to launch)

Inventory in Place
The surprise in this deal is that they have a starter amount of $150,000 inventory to turn. Based on typical metrics they should be able to turn this inventory into about $300,000 in sales by the end of the year. If they reinvest the profits into more inventory they could double sales in the following quarter assuming a constant sales force. This is very big news because investors won’t have to worry about facing dilution to keep sales momentum going.
Upcoming Catalysts
– Sales projections?– Significant Sales?– Regional distributors?– Roll Out New Products
The story of this company is in its infancy but the pedigree of the management and the proven track record in the nutraceutical space should give investors high confidence that this team will be able to execute on its business plan. The company has a simple business model of targeting a high margin product in an underserved market and growing sales exponentially. The inventory is a key ingredient in the maintenance of a successful product launch. The inventory stockpile considerably reduces the amount of dilution risk away. The company will be sales centric so there are many upcoming catalyst that could drive valuation higher. The stock is sitting at about a $1.3 mil market capitalization or close to one times projected annual sales. The supply of stock won’t last long at these levels.

http://psinvestor.com/grey-cloak-delivers-eqova-acquision-with-solid-structure-sets-stage-for-rebound/